Neola Medical AB (publ) (STO:NEOLA)

Neola Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.56	21.58	40.09	22.94	16.65
Cash & Short-Term Investments	19.56	21.58	40.09	22.94	16.65
Cash Growth	-9.38%	-46.17%	74.76%	37.80%	210.85%
Accounts Receivable	1.4	-	-	-	-
Other Receivables	-	20.9	1.02	1.45	0.56
Receivables	1.4	20.9	1.02	1.45	0.56
Inventory	0.08	-	-	-	-
Prepaid Expenses	-	0.63	0.49	0.4	0.22
Other Current Assets	-	-	-0	-	-0
Total Current Assets	21.04	43.11	41.6	24.79	17.43
Property, Plant & Equipment	0.2	0.14	0.22	0.16	0.01
Long-Term Deferred Charges	52.37	42.78	33.51	18.88	8.54
Other Long-Term Assets	-	-	-	0	-
Total Assets	73.61	86.02	75.33	43.83	25.97
Accounts Payable	-	2.18	1.49	1.3	0.95
Accrued Expenses	2	1.62	1.79	1.44	1.13
Current Income Taxes Payable	-	0.09	0.08	0.05	0.06
Other Current Liabilities	2.65	2.27	1.98	0.41	0.29
Total Current Liabilities	4.65	6.16	5.35	3.19	2.42
Other Long-Term Liabilities	-	0.83	2.5	-	-
Total Liabilities	4.65	6.99	7.85	3.19	2.42
Common Stock	68.96	3.98	3.98	1.5	0.75
Additional Paid-In Capital	-	80.11	79.56	44.83	21.84
Retained Earnings	-	-25.06	-16.05	-5.7	0.96
Comprehensive Income & Other	-	20	-	-	-0
Shareholders' Equity	68.96	79.03	67.49	40.63	23.55
Total Liabilities & Equity	73.61	86.02	75.33	43.83	25.97
Net Cash (Debt)	19.56	21.58	40.09	22.94	16.65
Net Cash Growth	-9.38%	-46.17%	74.76%	37.80%	210.85%
Net Cash Per Share	0.28	0.39	1.54	1.64	1.77
Filing Date Shares Outstanding	70.15	55.69	55.69	21.05	10.52
Total Common Shares Outstanding	70.15	55.69	55.69	21.05	10.52
Working Capital	16.39	36.95	36.26	21.59	15.01
Book Value Per Share	0.98	1.42	1.21	1.93	2.24
Tangible Book Value	68.96	79.03	67.49	40.63	23.55
Tangible Book Value Per Share	0.98	1.42	1.21	1.93	2.24
Machinery	-	0.31	0.31	0.2	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.